Cadila Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.75 Cr
as on 16-11-2024
- Company Age 51 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 27600.00%
(FY 2023)
- Ebitda
- Net Worth 5.58%
(FY 2023)
- Total Assets 7.59%
(FY 2023)
About Cadila Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Patel and Sharvil Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ1973PLC002286
- Company No.
002286
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 1973
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationNa, Gujarat
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cadila Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharvil Patel  | Director | 19-Apr-2003 | Current |
| Pankaj Patel | Director | 09-Mar-1978 | Current |
Financial Performance and Corporate Structure Insights of Cadila Laboratories.
Cadila Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 27600% increase in profit. The company's net worth moved up by a moderate rise of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cadila Laboratories?
In 2023, Cadila Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zydus Hospitals And Healthcare Research Private LimitedActive 16 years 6 monthsPankaj Patel and Sharvil Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cadila Laboratories?
Unlock and access historical data on people associated with Cadila Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cadila Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadila Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
